RecruitingPhase 2NCT06958536
A Study to Investigate Efficacy and Safety of Brivekimig in Participants With Crohn's Disease
Sponsor: Sanofi
Kansas City, KS · +19 more sites
Crohn's Disease clinical trials in Kansas City, KS
7 recruiting crohn's disease studies with a site in Kansas City, KS.
RecruitingPhase 3NCT06430801
A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
Sponsor: Merck Sharp & Dohme LLC
Kansas City, KS · Topeka, KS · +85 more sites
RecruitingPhase 1NCT03816345
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
Sponsor: National Cancer Institute (NCI)
Fairway, KS · Hays, KS · Kansas City, KS · +48 more sites
RecruitingPhase 3NCT06819891
A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease
Sponsor: Hoffmann-La Roche
Kansas City, KS · +60 more sites
RecruitingPhase 2NCT06233461
A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease
Sponsor: Takeda
Kansas City, KS · +29 more sites
RecruitingPhase 3NCT07184931
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
Sponsor: Sanofi
Kansas City, KS · +124 more sites
RecruitingPhase 4NCT06045754
A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease
Sponsor: Takeda
Kansas City, KS · Topeka, KS · +39 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.